Gross Profit Analysis: Comparing Pharming Group N.V. and Amneal Pharmaceuticals, Inc.

Pharmaceutical Giants' Profit Trends: 2014-2023

__timestamp	Amneal Pharmaceuticals, Inc.	Pharming Group N.V.
Wednesday, January 1, 2014	449634000	21595165
Thursday, January 1, 2015	499226000	6590427
Friday, January 1, 2016	597455000	11768542
Sunday, January 1, 2017	526178000	92587038
Monday, January 1, 2018	716403000	129203843
Tuesday, January 1, 2019	352997000	165412447
Wednesday, January 1, 2020	628393000	203056430
Friday, January 1, 2021	768973000	169670071
Saturday, January 1, 2022	784708000	188060000
Sunday, January 1, 2023	820565000	220104000

Data in motion

A Tale of Two Pharmaceutical Giants: Gross Profit Trends from 2014 to 2023

In the ever-evolving pharmaceutical industry, understanding financial health is crucial. This analysis compares the gross profit trends of Pharming Group N.V. and Amneal Pharmaceuticals, Inc. over a decade, from 2014 to 2023.

Amneal Pharmaceuticals, Inc. has shown a robust growth trajectory, with its gross profit increasing by approximately 82% over the period. Notably, 2023 marked its peak, with a gross profit of over 820 million, reflecting a strong market position. In contrast, Pharming Group N.V. experienced a remarkable growth spurt, with its gross profit surging by over 900% from 2014 to 2023. This growth underscores its strategic advancements and market penetration.

These insights highlight the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions significantly impact financial outcomes.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025